BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Contract Services

Vibalogics to expand cGMP manufacturing capacity for viral vectors

The investment by the CDMO, which specializes in the production of oncolytic viruses, viral vector vaccines and viral vector gene therapy products includes...

June 17, 2021 | News

Medidata to Offer Secure Platform for Decentralization of Clinical Trials

The first company in the world to unify direct patient data capture technology with study oversight and monitoring, Medidata redefines end-to-end...

June 16, 2021 | News

Novavax Announces Positive Data for COVID-19 Beta (B.1.351) Variant Strain Vaccine

Novavax Announces Positive Data from Three Complementary Studies of COVID-19 Beta (B.1.351) Variant Strain Vaccine - Primates boosted with rS-B.1.351 vacc...

June 12, 2021 | News

WuXi XDC and LCB Signed MOU for the Development and Manufacturing of Antibody-drug Conjugates

Under the partnership, LCB will have access to XDC' integrated services in mAb, linker, payload, analytical and formulation development as well as ADC drug...

June 10, 2021 | News

21% were not aware Australian data is accepted by the FDA and other major regulatory authorities

The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical announced the results o...

June 04, 2021 | Analysis

Samsung Biologics to add mRNA vaccine DS production capability

Samsung Biologics, a global leading CDMO, will add mRNA vaccine DS production capability to its existing facility by the first half of 2022 The addition...

June 01, 2021 | News

Avance Clinical Releases Industry Survey Results at BIO Korea 2021

The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical shared results of a rec...

May 27, 2021 | News

Vetter Once Again Wins Axia Best Managed Companies Award

§ Internationally renowned seal of quality for exemplary corporate management § Positive assessment of strategy, innovatio...

May 26, 2021 | News

PPD Opens Multipurpose Clinical Research Laboratory in China

PPD, Inc. (Nasdaq:PPD), a leading global contract research organization, is opening a new laboratory in Suzhou, China, to support China-base...

May 26, 2021 | News

Moderna and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine

Moderna (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Samsung Biologics (KRX: 207940.KS), a leadin...

May 24, 2021 | News

WuXi XDC to Provide Fully Integrated Bioconjugate CDMO Services

Per the terms of the joint venture agreement, WuXi Biologics and WuXi STA will make capital contributions of USD120 million and USD8...

May 14, 2021 | News

ERS Genomics and GenScript Biotech Corporation sign CRISPR/Cas9 license agreement

ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier...

May 12, 2021 | News

German CDMO Richter-Helm Triples to Accommodate Global Market Demand

“The market for pharmaceutical biotechnology has been continuously growing and further growth is expected. In order to accommodate demand for high va...

May 09, 2021 | News

Stay Connected